Brad Burge: Psychedelic Therapy

2024-03-25

In this episode of the Nick Standlea Show, we journey into the world of psychedelic therapies, exploring the use of psilocybin, MDMA, LSD, ketamine, and ayahuasca for treating conditions such as depression, anxiety, and PTSD. We unpack the efficacy of psychedelics for treating PTSD, depression, anxiety, and maladies. We also examine the potential dangers of unregulated psychedelics and discuss the importance of set, setting, and integration in psychedelic therapy to amplify positive outcomes. Nick's guest is Brad Burge, a Stanford University alumni who has devoted his professional life to psychedelic research as the communications director for ...

Nick's guest is Brad Burge, a Stanford University alumni who has devoted his professional life to psychedelic research as the communications director for Multidisciplinary Association for Psychedelic Studies (MAPS) and at his own PR firm for the psychedelic industry, Integration Communications.

Brad shares his personal mental health journey and the positive role that psychedelics played within it. The conversation turns to MDMA therapy for PTSD, illustrating its transformation from recreational drug to potential therapeutic treatment. We explore the FDA approval process, the funding potential, the possible shift in cultural and political perspectives, and the emergence of an industry centered around psychedelic therapy.

We discuss the missteps of the Drug Abuse Resistance Education (D.A.R.E.) Program, but also emphasize responsible usage and regulated control of psychedelics.

We explore the role of Ketamine in treating mental health issues, particularly depression. A discussion on off-label prescribing, accessibility, effectiveness, and potential abuses highlights the complex reality of the field.

Ultimately, the episode underscores the need for responsible, systematic, and well-regulated administration of psychedelic therapy. The dialogue seeks to address the lack of robust and accessible support systems, touches on how the pharma industry fits into the psychedelic therapy landscape, and highlights the importance of educating providers about the process of integration after a psychedelic experience.

This episode is a must-listen for those interested in the field of psychedelic therapy, public health policy, and alternative treatments for mental health.

Now on YouTube!

Psychedelic Therapies: Brad Burge: https://youtu.be/hlX2KOmvQiI

Category: Medical

Please support this podcast by checking out our sponsor:

Test Prep Gurus:

https://www.prepgurus.com

@TestPrepGurus

https://www.instagram.com/testprepgurus/

EPISODE LINKS:

Brad Burge, LinkedIn: https://www.linkedin.com/in/brad-burge-84326728/

Integration Communications:

Website: https://integrationcommunications.com/